<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37083780</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>16</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>21</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Flail arm syndrome due to duplication mutations in the SMN1 gene: A case report.</ArticleTitle><Pagination><StartPage>e33565</StartPage><MedlinePgn>e33565</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e33565</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000033565</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Flail arm syndrome (FAS) only involves the upper limbs early stage and manifests as proximal weakness and atrophy of both upper limbs and decreased tendon reflexes. As a benign variant type of amyotrophic lateral sclerosis, FAS progresses slowly, with no lower motor neuron signs in the lower limbs or bulbar muscles within 12 months after onset.</AbstractText><AbstractText Label="PATIENT CONCERNS" NlmCategory="METHODS">A 49-year-old male patient was admitted to the hospital with a 15-month history of proximal weakness and muscle atrophy in both upper limbs. His other symptoms and signs were not obvious.</AbstractText><AbstractText Label="DIAGNOSES" NlmCategory="METHODS">Gene test results indicated that there were duplication mutations in the exon 7 to 8 region of the SMN1 gene.</AbstractText><AbstractText Label="LESSONS" NlmCategory="CONCLUSIONS">The abnormal duplication of exons 7 and 8 of the SMN1 gene in this patient may increase the risk of FAS. Further studies are needed to identify the dominant genes and genetic factors causing males to be susceptible to FAS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Han</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Bo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4398-0390</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C526471">SMN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055533">Survival of Motor Neuron 1 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001132" MajorTopicYN="Y">Arm</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009133" MajorTopicYN="N">Muscular Atrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055533" MajorTopicYN="N">Survival of Motor Neuron 1 Protein</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>14</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37083780</ArticleId><ArticleId IdType="pmc">PMC10118368</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000033565</ArticleId><ArticleId IdType="pii">00005792-202304210-00019</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vulpian A. Maladies du Syst&#xe8;me Nerveux (Moelle &#xe9;pini&#xe8;re). Paris: Octave Dion; 1886: 346.</Citation></Reference><Reference><Citation>Rinaldi F, Todeschini A, Rota S, et al. . A very slowly progressive neurogenic &#x201c;man-in-the-barrel&#x201d; syndrome. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:425&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25707269</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbohm A, Del Tredici K, Braak H, et al. . Involvement of cortico-efferent tracts in flail arm syndrome: a tract-of-interest-based DTI study. J Neurol. 2022;269:2619&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9021061</ArticleId><ArticleId IdType="pubmed">34676447</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauw HM, Barnes CP, van Vught PW, et al. . SMN1 gene duplications are associated with sporadic ALS. Neurology. 2012;78:776&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3304946</ArticleId><ArticleId IdType="pubmed">22323753</ArticleId></ArticleIdList></Reference><Reference><Citation>Sage JI, Van Uitert RL. Man-in-the-barrel syndrome. Neurology. 1983;36:1102&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">3736874</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromicho M, Santos MO, Pinto S, et al. . The flail-arm syndrome: the influence of phenotypic features. Amyotroph Lateral Scler Frontotemporal Degener. 2023:1&#x2013;6. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="pubmed">36600571</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Mathers S, Talman P, et al. . Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72:1087&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2821838</ArticleId><ArticleId IdType="pubmed">19307543</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu MT, Ellis CM, Al-Chalabi A, et al. . Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1998;65:950&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2170397</ArticleId><ArticleId IdType="pubmed">9854987</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zhang B, Chen R, et al. . Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. J Neurol Neurosurg Psychiatry. 2015;86:1075&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">26124198</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Tang L, Fan D. Twelve-month duration as an appropriate criterion for flail arm syndrome. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:29&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">31523989</ArticleId></ArticleIdList></Reference><Reference><Citation>Shields LBE, Iyer VG, Zhang YP, et al. . Person-in-the-barrel syndrome following cervical spine surgery: illustrative case. J Neurosurg Case Lessons. 2021;1:CASE20165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9241343</ArticleId><ArticleId IdType="pubmed">35855313</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubers A, Hildebrandt V, Petri S, et al. . Clinical features and differential diagnosis of flail arm syndrome. J Neurol. 2016;263:390&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">26705123</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon BN, Choi SH, Rha JH, et al. . Comparison between flail arm syndrome and upper limb onset amyotrophic lateral sclerosis: clinical features and electromyographic findings. Exp Neurobiol. 2014;23:253&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4174617</ArticleId><ArticleId IdType="pubmed">25258573</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S, Sekiguchi K, Noda Y, et al. . Clinical utility of repetitive nerve stimulation test in differentiating multifocal motor neuropathy from progressive muscular atrophy. J Clin Neuromuscul Dis. 2022;23:175&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9126258</ArticleId><ArticleId IdType="pubmed">35608640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M, Emerson CP, Jr., Hayward LJ. Outcome measures in facioscapulohumeral muscular dystrophy clinical trials. Cells. 2022;11:687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8870318</ArticleId><ArticleId IdType="pubmed">35203336</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnally CJ, 3rd, Patel PD, Canseco JA, et al. . Current management of cervical spondylotic myelopathy. Clin Spine Surg. 2022;35:E68&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">34379614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill JR, Lanier ST, Brogan DM, et al. . Management of adult brachial plexus injuries. J Hand Surg Am. 2021;46:778&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">34158206</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chio A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Zhan F, Yao Y, et al. . Clinical heterogeneity in a family with flail arm syndrome and review of hnRNPA1-related spectrum. Ann Clin Transl Neurol. 2022;9:1910&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9735363</ArticleId><ArticleId IdType="pubmed">36314424</ArticleId></ArticleIdList></Reference><Reference><Citation>Detering NT, Schuning T, Hensel N, et al. . The phospho-landscape of the survival of motoneuron protein (SMN) protein: relevance for spinal muscular atrophy (SMA). Cell Mol Life Sci. 2022;79:497.</Citation><ArticleIdList><ArticleId IdType="pubmed">36006469</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochette CF, Surh LC, Ray PN, et al. . Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7. Neurogenetics. 1997;1:141&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10732817</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisse M, Zwamborn RAJ, van Vugt J, et al. . The effect of SMN gene dosage on ALS risk and disease severity. Ann Neurol. 2021;89:686&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8048961</ArticleId><ArticleId IdType="pubmed">33389754</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Vourc&#x2019;h P, Blasco H, et al. . Phenotypic and genotypic studies of ALS cases in ALS-SMA families. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:432&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">29493298</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>